Cargando…
Novel site-specific PEGylated L-asparaginase
L-asparaginase (ASNase) from Escherichia coli is currently used in some countries in its PEGylated form (ONCASPAR, pegaspargase) to treat acute lymphoblastic leukemia (ALL). PEGylation refers to the covalent attachment of poly(ethylene) glycol to the protein drug and it not only reduces the immune s...
Autores principales: | Meneguetti, Giovanna Pastore, Santos, João Henrique Picado Madalena, Obreque, Karin Mariana Torres, Barbosa, Christiano Marcello Vaz, Monteiro, Gisele, Farsky, Sandra Helena Poliselli, Marim de Oliveira, Adriano, Angeli, Claudia Blanes, Palmisano, Giuseppe, Ventura, Sónia Patrícia Marques, Pessoa-Junior, Adalberto, de Oliveira Rangel-Yagui, Carlota |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6372183/ https://www.ncbi.nlm.nih.gov/pubmed/30753228 http://dx.doi.org/10.1371/journal.pone.0211951 |
Ejemplares similares
-
Correction: Novel site-specific PEGylated L-asparaginase
por: Meneguetti, Giovanna Pastore, et al.
Publicado: (2019) -
Peg-Grafted Liposomes for L-Asparaginase Encapsulation
por: de Souza Guimarães, Marina, et al.
Publicado: (2022) -
Development of L-Asparaginase Biobetters: Current Research Status and Review of the Desirable Quality Profiles
por: Brumano, Larissa Pereira, et al.
Publicado: (2019) -
From Synthesis to Characterization of Site-Selective PEGylated Proteins
por: Belén, Lisandra Herrera, et al.
Publicado: (2019) -
Recombinant L-asparaginase 1 from Saccharomyces cerevisiae: an allosteric enzyme with antineoplastic activity
por: Costa, Iris Munhoz, et al.
Publicado: (2016)